To which specialist should patients with hematuria be referred?

Urology Referral for Hematuria

Patients with hematuria should be referred to urology, not nephrology, unless there are specific indicators of primary renal (glomerular) disease. 1

Algorithmic Approach to Specialist Referral

Immediate Urology Referral Required:

• All adults with gross hematuria (even if self-limited) 1

  • Cancer risk consistently >10% and can exceed 25% in referral series
  • Painless gross hematuria has particularly strong association with malignancy
  • Do NOT wait for resolution—refer urgently

• Microscopic hematuria (≥3 RBCs/HPF) with:

  • No identifiable benign cause 1
  • History of smoking 2
  • Occupational chemical/dye exposure 2
  • Age >40 years with risk factors 2
  • Irritative voiding symptoms without infection 2
  • Abnormal urine cytology 2

Nephrology Referral Instead:

Refer to nephrology (NOT urology) when clinical features suggest primary renal parenchymal disease 2, 3:

• Significant proteinuria: >1,000 mg/24 hours (or >500 mg/24 hours if persistent/increasing) 2
• Red cell casts in urine sediment 2
• Dysmorphic RBCs (>5% acanthocytes on microscopy) 4
• Elevated serum creatinine 2, 5
• Hypertension with proteinuria 6

Key Clinical Pitfalls:

1. Don't dismiss self-limited gross hematuria—19.8% of patients with microscopic hematuria who are specifically asked report recent visible hematuria, associated with 7.2-fold increased cancer risk 1

2. Anticoagulation is NOT an excuse to skip evaluation—pursue full workup even in patients on antiplatelet or anticoagulant therapy 1

3. Confirm microscopic hematuria properly before referral:

   • Dipstick positive → confirm with microscopy showing ≥3 RBCs/HPF 1
   • Exclude benign causes first (menstruation, vigorous exercise, UTI, trauma) 2

4. Don't order urine cytology or molecular markers in primary care—these are not indicated for initial hematuria evaluation 1

The Urology Workup Includes:

Once referred, urologists perform cystoscopy (to detect bladder cancer, which represents the majority of hematuria-associated malignancies) plus upper tract imaging 1, 5. This comprehensive evaluation addresses the fact that upper and lower tract pathologies often coexist 7.

Real-World Context:

Current data show significant under-referral—only 14.1% of patients with hematuria receive appropriate specialist evaluation within 6 months 8. This contributes to delayed bladder cancer diagnosis, which increases cancer-specific mortality by 34% and all-cause mortality by 15% 5. Primary care physicians must maintain high vigilance, particularly since surveys show many providers inappropriately fail to refer even gross hematuria 1.